Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 May 16;63(9):1608–1614. doi: 10.1002/pbc.26061

TABLE I.

Patient Characteristics

Characteristic No. (%)
Age at initiation of IMRT
    1-5 years 9 (30.0)
    6-10 years 12 (40.0)
    11-15 years 6 (20.0)
    16-20 years 3 (10.0)
Gender
    Male 11 (36.7)
    Female 19 (63.3)
Race
    Caucasian 26 (86.7)
    African American 3 (10.0)
    Asian 1 (3.3)
Tumor subsite
    Parameningeal 24 (80.0)
        Infratemporal fossa 10
        Nasopharynx 7
        Paranasal sinus 3
        Ethmoid sinus 2
        Parapharyngeal region 2
    Orbit 4 (13.3)
    Neck 1 (3.3)
    Buccal 1 (3.3)
Histology
    Embryonal/botryoid 22 (73.3)
    Alveolar/undifferentiated 8 (26.7)
Surgery
    Biopsy only 24 (80.0)
    Resection (subtotal or total) 6 (20.0)
Chemotherapy
    Any 30 (100)
        Alkylators 29 (96.7)
        Anthracyclines 21 (70.0)